Cyclosporine induces myocardial connective tissue growth factor in spontaneously hypertensive rats on high-sodium diet

Transplantation

Volumn 71, Issue 7, 2001, Pages 951-958

  Finckenberg, Piet ^a   Lassila, Markus ^a   Inkinen, Kaija ^b   Pere, Anna Kaisa ^a   Krogerus, Leena ^b   Lindgren, Leena ^b   Mervaala, Eero ^a   Vapaatalo, Heikki ^a   Nurminen, Marja Leena ^a   Ahonen, Juhani ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; COLLAGEN TYPE 1; COLLAGEN TYPE 3; CONNECTIVE TISSUE GROWTH FACTOR; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; SODIUM; VALSARTAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOTOXICITY; CELL STRUCTURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; HEART INFARCTION; HEART MUSCLE CELL; HYPERTENSION; IN SITU HYBRIDIZATION; MALE; NEPHROTOXICITY; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SCORING SYSTEM; SIGNAL TRANSDUCTION; SODIUM INTAKE; VASCULAR DISEASE; VASCULAR LESION;

EID: 0035870786     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200104150-00021     Document Type: Article

References (69)

1. Cyclosporine-induced hypertension after transplantation
2. Cyclosporine nephropathy: Pathophysiology and clinical impact
3. Improved graft survival after renal transplantation in the United States, 1988 to 1996
4. The long-term course of cyclosporine-associated chronic nephropathy
5. Role of thromboxane and angiotensin in cyclosporine-induced renal vasoconstriction in the dog
6. Sequential agonist activation and site-specifc mediation of acute cyclosporine constriction in rat renal arterioles
7. Changes in the venous compliance by bradykinin and angiotensin II and its significance for the vascular effects of cyclosporine-A
8. 2 to prostacyclin in association with increased blood pressure in patients on cyclosporine A
9. Cyclosporine induced alterations in vasopressin signalling in the glomerular mesangial cell
10. Comparison of the effects of cyclosporine and its metabolites on the release of prostacyclin and endothelin from mesangial cells
11. Cyclosporine-induced stimulation of the renin-angiotensin system after liver and heart transplantation
12. Cyclosporine A induces endothelin-1 release from cultured rat vascular smooth muscle cells
13. 2 in rat renal mesangial cells
14. Hypertension and other risk factors in coronary heart disease
15. Human atherosclerosis: I. Cell constitution and characteristics of advanced lesions of the superficial femoral artery
16. Relative distribution of fibronectin and type I, III, IV, V collagens in normal and atherosclerotic intima in human arteries
17. Mechanisms of disease: Atherosclerosis-an inflammatory disease
18. Collagen synthesis in atherosclerosis: Too much and not enough
19. 1 and matrix proteins in cyclosporine nephropathy
20. An endothelin-transforming growth factor β pathway in the nephrotoxicity of immunosuppressive drugs
21. Link between angiotensin II and TGFβ in the kidney
22. Cyclosporine induces cancer progression by a cell-autonomous mechanism
23. Connective tissue growth factor: A cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10
24. Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor
25. Human connective tissue growth factor is expressed in advanced atherosclerotic lesions
26. Increased expression of connective tissue growth factor in the infarct zone of experimentally induced myocardial infarction in rats
27. Expression of connective tissue growth factor in human renal fibrosis
28. Effects of ACE inhibition on cyclosporine A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats on high sodium diet
29. Pharmacological profile of valsartan, a non-peptide angiotensin II type I receptor antagonist. 1st communication: Anti-hypertensive effect of valsartan in hypertensive models
30. Effects of dietary sodium and magnesium on cyclosporine A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats
31. Serum creatinine determination without protein precipitation
32. Protein measurement with the Folin phenol reagent
33. Type V collagen in experimental granulation tissue
34. Construction of DNA sequences complementary to rat alpha 1 and alpha 2 collagen mRNA and their use in studying the regulation of type I collagen synthesis by 1,25-dihydroxyvitamin D
35. Cloning of cDNA for rat proα1 (III) collagen mRNA: Different expression patterns of type I and type III collagen and fibronectin genes in experimental granulation tissue
36. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction
37. Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family
38. Comparison of enalapril and valsartan in cyclosporine A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats on high sodium diet
39. Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis
40. Hypoxia increases thrombospondin-1 transcript and protein in cultured endothelin cells
41. Collagen metabolism in cultured adult rat cardiac fibroblasts: Response to angiotensin II and aldosterone
42. Angiotensin II and connective tissue: Homeostasis and reciprocal regulation
43. Angiotensin II as a risk factor for cyclosporin nephrotoxicity in patients with psoriasis
44. Suppression of plasma renin activity by cyclosporine
45. The long-term course of cyclosporine-associated chronic nephropathy
46. Cyclosporine and the renin-angiotensin system
47. Pathogenesis of cyclosporine nephropathy: Roles of angiotensin II and osteopontin
48. Accumulation of acidic renin isoforms in kidneys of cyclosporine A-treated rats
49. Chronic cyclosporin A nephrotoxicity, P-glycoprotein overexpression, and relationships with intrarenal angiotensin II deposits
50. Role of intrarenal endothelin 1, endothelin 3, and angiotensin II expression in chronic cyclosporin A nephrotoxicity in rats
51. Cyclosporine A up-regulates angiotensin II receptors and calcium responses in human vascular smooth muscle cells
52. Osteopontin expression in angiotensin II-induced tubulointerstitial nephritis
53. Angiotensin II in renal fibrosis: Should TGF-β rather than blood pressure be the therapeutic target?
54. Modulation of leukocyte-mediated myocardial reperfusion injury
55. Cyclosporin-A reduces leukocyte accumulation and protects against myocardial ischaemia reperfusion injury in rats
56. Cyclosporin A inhibits smooth muscle proliferation in the vascular response to injury
57. Effect of increasing doses of angiotensin II infused into normal and hypertensive Wistar rats on low density lipoprotein and fibrinogen uptake by aortic walls
58. Spontaneously hypertensive rats are resistant to the development of hypercholesterolemia
59. Effects of sodium intake on inherited hypertension in the rat
60. Beneficial effects of a potassium- and magnesium-enriched salt alternative
61. Dietary salt intake: A determinant of cardiac involvement in essential hypertension
62. Sodium intake modulates left ventricular hypertrophy in essential hypertension
63. Effect of salt on the vascular lesions of spontaneously hypertensive rats
64. Induction of cardiac angiotensin I-converting enzyme with dietary NaCl-loading in genetically hypertensive and normotensive rats
65. Increased gene expression of angiotensin II type 1A receptor in aortic smooth muscle cells of cyclosporin A-induced hypertensive rats
66. Prevention of cardiac hypertrophy by calcineurin inhibition: Hope or hype?
67. ACE inhibitors and angiotensin II antagonists in renal transplantation: An analysis of safety and efficacy
68. Is it time for ACE inhibitors in chronic allograft nephropathy?
69. CTGF expression is induced by TGF-beta in cardiac fibroblasts and cardiac myocytes: A potential role in heart fibrosis